| Dr Isioma Aninyei, MD | |
|
401 Takoma Ave, Greeneville, TN 37743-4647 | |
| (828) 687-5616 | |
| (828) 650-8076 |
| Full Name | Dr Isioma Aninyei |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 23 Years |
| Location | 401 Takoma Ave, Greeneville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235450248 | NPI | - | NPPES |
| P01476605 | Other | TN | RAIL ROAD MEDICARE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkridge Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospital Medicine Services Of Tn Llc | 2365807633 | 203 |
News Archive
Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted a Priority Review designation to its Supplemental New Drug Application (sNDA) for REVLIMID (lenalidomide) for the treatment of relapsed or refractory multiple myeloma.
Obese patients with chronic obstructive pulmonary disease stand to gain as much from pulmonary rehabilitation as their slimmer counterparts, even though as a group they have a lower exercise capacity, according to new research from the University Hospitals of Leicester in the UK.
ProUroCare Medical, Inc., a provider of proprietary medical imaging products, indicates that the Food and Drug Administration has informed the industry that the processing of 510(k) applications, which includes the ProUroScan™ prostate imaging system, has been delayed because of the inclement weather in February that impacted the Washington, D.C. area.
Decades before people with Alzheimer's disease develop memory loss and confusion, their brains become dotted with plaques made of a sticky protein - called amyloid beta - that is thought to contribute to the disease and its progression.
› Verified 3 days ago
| Entity Name | Summit Medical Group, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659090298 PECOS PAC ID: 2860396330 Enrollment ID: O20031125000793 |
News Archive
Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted a Priority Review designation to its Supplemental New Drug Application (sNDA) for REVLIMID (lenalidomide) for the treatment of relapsed or refractory multiple myeloma.
Obese patients with chronic obstructive pulmonary disease stand to gain as much from pulmonary rehabilitation as their slimmer counterparts, even though as a group they have a lower exercise capacity, according to new research from the University Hospitals of Leicester in the UK.
ProUroCare Medical, Inc., a provider of proprietary medical imaging products, indicates that the Food and Drug Administration has informed the industry that the processing of 510(k) applications, which includes the ProUroScan™ prostate imaging system, has been delayed because of the inclement weather in February that impacted the Washington, D.C. area.
Decades before people with Alzheimer's disease develop memory loss and confusion, their brains become dotted with plaques made of a sticky protein - called amyloid beta - that is thought to contribute to the disease and its progression.
› Verified 3 days ago
| Entity Name | Takoma Regional Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699819003 PECOS PAC ID: 8729189295 Enrollment ID: O20070727000394 |
News Archive
Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted a Priority Review designation to its Supplemental New Drug Application (sNDA) for REVLIMID (lenalidomide) for the treatment of relapsed or refractory multiple myeloma.
Obese patients with chronic obstructive pulmonary disease stand to gain as much from pulmonary rehabilitation as their slimmer counterparts, even though as a group they have a lower exercise capacity, according to new research from the University Hospitals of Leicester in the UK.
ProUroCare Medical, Inc., a provider of proprietary medical imaging products, indicates that the Food and Drug Administration has informed the industry that the processing of 510(k) applications, which includes the ProUroScan™ prostate imaging system, has been delayed because of the inclement weather in February that impacted the Washington, D.C. area.
Decades before people with Alzheimer's disease develop memory loss and confusion, their brains become dotted with plaques made of a sticky protein - called amyloid beta - that is thought to contribute to the disease and its progression.
› Verified 3 days ago
| Entity Name | Wellmont Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780986257 PECOS PAC ID: 8123291739 Enrollment ID: O20111026000909 |
News Archive
Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted a Priority Review designation to its Supplemental New Drug Application (sNDA) for REVLIMID (lenalidomide) for the treatment of relapsed or refractory multiple myeloma.
Obese patients with chronic obstructive pulmonary disease stand to gain as much from pulmonary rehabilitation as their slimmer counterparts, even though as a group they have a lower exercise capacity, according to new research from the University Hospitals of Leicester in the UK.
ProUroCare Medical, Inc., a provider of proprietary medical imaging products, indicates that the Food and Drug Administration has informed the industry that the processing of 510(k) applications, which includes the ProUroScan™ prostate imaging system, has been delayed because of the inclement weather in February that impacted the Washington, D.C. area.
Decades before people with Alzheimer's disease develop memory loss and confusion, their brains become dotted with plaques made of a sticky protein - called amyloid beta - that is thought to contribute to the disease and its progression.
› Verified 3 days ago
| Entity Name | Hospital Medicine Services Of Tn Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982301065 PECOS PAC ID: 2365807633 Enrollment ID: O20230421000177 |
News Archive
Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted a Priority Review designation to its Supplemental New Drug Application (sNDA) for REVLIMID (lenalidomide) for the treatment of relapsed or refractory multiple myeloma.
Obese patients with chronic obstructive pulmonary disease stand to gain as much from pulmonary rehabilitation as their slimmer counterparts, even though as a group they have a lower exercise capacity, according to new research from the University Hospitals of Leicester in the UK.
ProUroCare Medical, Inc., a provider of proprietary medical imaging products, indicates that the Food and Drug Administration has informed the industry that the processing of 510(k) applications, which includes the ProUroScan™ prostate imaging system, has been delayed because of the inclement weather in February that impacted the Washington, D.C. area.
Decades before people with Alzheimer's disease develop memory loss and confusion, their brains become dotted with plaques made of a sticky protein - called amyloid beta - that is thought to contribute to the disease and its progression.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Isioma Aninyei, MD 401 Takoma Ave, Greeneville, TN 37743-4647 Ph: (423) 278-1743 | Dr Isioma Aninyei, MD 401 Takoma Ave, Greeneville, TN 37743-4647 Ph: (828) 687-5616 |
News Archive
Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted a Priority Review designation to its Supplemental New Drug Application (sNDA) for REVLIMID (lenalidomide) for the treatment of relapsed or refractory multiple myeloma.
Obese patients with chronic obstructive pulmonary disease stand to gain as much from pulmonary rehabilitation as their slimmer counterparts, even though as a group they have a lower exercise capacity, according to new research from the University Hospitals of Leicester in the UK.
ProUroCare Medical, Inc., a provider of proprietary medical imaging products, indicates that the Food and Drug Administration has informed the industry that the processing of 510(k) applications, which includes the ProUroScan™ prostate imaging system, has been delayed because of the inclement weather in February that impacted the Washington, D.C. area.
Decades before people with Alzheimer's disease develop memory loss and confusion, their brains become dotted with plaques made of a sticky protein - called amyloid beta - that is thought to contribute to the disease and its progression.
› Verified 3 days ago
Bukola O Afilaka, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1420 Tusculum Blvd, Greeneville, TN 37745 Phone: 423-787-5000 | |
George B. Kehler Ii, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1420 Tusculum Blvd, Greeneville, TN 37745 Phone: 423-787-5000 | |
David H Beals, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1420 Tusculum Blvd, Greeneville, TN 37745 Phone: 423-787-5000 |